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IODINE STATUS OF PREGNANT HAITIAN-AMERICAN WOMEN 
AMANDA RACHEL SEGAL 
ABSTRACT 
 Iodine is an essential element for the production of thyroid hormone, which is 
required for fetal cognitive development during pregnancy.  Changes in maternal 
metabolism and physiology increase iodine requirements, and even mild iodine 
deficiency may lead to adverse effects on fetal neurodevelopment.  While overall iodine 
intake in the United States is considered to be sufficient, there have been recent concerns 
about mild deficiency among women of childbearing years. Potentially exacerbating this 
issue amongst Haitian-American women is the known occurrence of iodine deficiency in 
Haiti.  Attempts to supplement iodized salt by UNICEF have been unsuccessful due to 
Haiti’s current political climate.  Haitian immigrant women living in the United States 
may be at particular risk for iodine deficiency during pregnancy due to their unique 
dietary patterns.  We conducted a cross-sectional study of 21 pregnant Haitian women 
living in the Boston area in order to determine if they are ingesting adequate dietary 
iodine.  Our subjects included women with singleton pregnancies, who were not taking 
any thyroid hormone or anti-thyroid medication, and who were recruited at the Antenatal 
Clinic at Boston Medical Center.  We obtained spot urine iodine concentrations, as well 
as information pertaining to iodine-containing prenatal vitamin use.  To date, this has 
been the only such study carried out in this particularly vulnerable ethnic group and this 
study provides information of public health importance.   
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INTRODUCTION 
 
Thyroid Hormone Production and Regulation 
Low thyroid hormone levels stimulate the hypothalamus, which is located at the 
base of the brain, to release thyroid releasing hormone (TRH), which positively 
stimulates the anterior pituitary gland to release thyroid stimulating hormone (TSH).  
TSH then stimulates the thyroid gland to produce the thyroid hormones Thyroxine (T4) 
and Triiodothyronine (T3).  High levels of thyroid hormone negatively signal both the 
hypothalamus and anterior pituitary, thereby controlling the release of TRH and TSH and 
creating a negative feedback loop. 
Thyroid hormone production, which requires an adequate consumption of iodine, 
a crucial micronutrient provided through diet, is essential for fetal neurodevelopment.  
Adequate intake of dietary iodine is needed to minimize thyroid dysfunction in the 
population. Once consumed, up to 80% of absorbed iodide is taken up by the thyroid 
gland (1).  Both TSH and plasma iodine levels regulate thyroidal iodine uptake. The 
active process of transporting iodine from the blood into the thyroid gland is 
accomplished by the sodium-iodine symporter (NIS), a protein located on the basolateral 
membrane of the thyroid epithelial cells (2). Upon entering the thyroid gland, iodine is 
used to iodinate tyrosine residues on thyroglobulin, thus forming both monoiodotyrosine 
(MIT) and diiodotyrosine (DIT).  The thyroid hormones T4 and T3 are generated through 
the coupling of 2 DITs or 1 DIT and 1 MIT together through the formation of diether 
bridges (3 & 4).  While T3 is the active form of the thyroid hormone, the thyroid gland 
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produces a much higher proportion of T4, which is converted to T3 in the peripheral 
tissues. Within the thyroid gland, mature thyroglobulin contains 0.1-1% of its mass in 
iodine and is stored extracellularly in the luminal colloid of the follicle.  Following 
endocytosis, lysosomal and endosomal proteases digest the thyroglobulin, thus releasing 
T3 and T4 into the bloodstream.  Since T4 binds to the thyroxine-binding globulin (TBG) 
more tightly than T3, it has a longer half-life in circulation.  TBG is synthesized in the 
liver and has a single iodothyronine-binding site. The metabolism of thyroid hormone via 
deiodinases causes the released iodine to either be recycled by the thyroid gland or be 
released into the urine through the kidneys (5).  The kidneys ultimately excrete 90% of 
the iodine consumed (5). 
 
Figure 1: Iodine Pathway in the Thyroid Cell, taken from Trumpff et al. (6) 
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Sources of Iodine 
Iodine is widely but unevenly distributed throughout the world, with its majority 
being found in oceans.  Foods of marine origin, therefore, contain a relatively high 
concentration of natural iodine. Iodine, which is oxidized in the seawater from iodide, is 
volatile and enters the earth’s atmosphere, where it is returned to the soil via rain (7).  
However, in several regions of the world (including Haiti), iodine cycling is not sufficient 
and results in iodine-depleted soil and water. Agricultural crops and animals raised in 
these regions, therefore, will be low in iodine levels. Populations living in these regions 
will experience iodine deficiency unless iodine is supplemented through dietary sources. 
The spraying of commercial salt with iodide may reverse iodine deficiency in populations, 
and the iodization of salt continues to be the main strategy to eliminate iodine deficiency 
in the world (8).  
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Table 1: Iodine content of composites of food categories, taken from Vought et al. 
(9) 
  
In the United States, the median daily intake of iodine in 2003-2004 was 
determined to be around 200-285 µg/d in males and 140-200 µg/d in females (11). A 
major source of dietary iodine is through salt fortified with iodine.  Salt iodization is a 
useful, effectively distributed and inexpensive way to ensure iodine sufficiency in a 
population.  Approximately 120 countries around the world have implemented the use of 
iodized salt as a public health effort (12).  The U.S. Food and Drug Administration 
(FDA) recommends 60-100 mg KI/kg salt, which is equivalent to 46-76 mg I/kg salt (12).  
However, salt iodization had never been mandated in the United States and the majority 
of salt consumed is not iodized.  Another source of iodine in the U.S. is some bread, due 
to the use of iodate conditioners (13 & 14). The dairy industry utilizes iodophor cleansers 
and supplements cattle feed with iodine.  Although these practices are not done for public 
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health purposes, currently dairy products are the major U.S. dietary source of iodine (14). 
While variable amounts of iodine are found in meat and seafood, it has been established 
by the FDA that the main US non-salt dietary iodine sources are found in bread and dairy 
products (15). 
 
Assessing Population Iodine Status 
 Other than urinary iodine concentration measurements as a biomarker for iodine 
intake, both thyroglobulin and goiter ultrasounds serve as indicators of adequate iodine 
intake.  Serum thyroglobulin is elevated during times of iodine deficiency, mainly due to 
high levels of circulating TSH and thyroidal hyperplasia (17).  The prevalence of a goiter 
is an indicator of the severity of iodine deficiency disorders in a population (18).  
Inspection and palpation of the goiter are typically used to classify the goiter, however in 
areas of mild-to-moderate iodine deficiency, the measurement of thyroid volume through 
ultrasound is the preferred method (8).  This method of examination is desirable since it 
is noninvasive, quick and can be performed in remote areas; however it requires valid 
references from iodine-sufficient populations in order for screening to be accurate.  The 
results of a thyroid ultrasound are subjective since the measurements and findings of 
thyroid size and diameter require judgment an experience and different ultrasound 
techniques may produce interobserver errors of the Thyroid volume as high as 26% (19). 
In order to improve the reliability of thyroid volume measurements through ultrasounds, 
it is important to standardize the process worldwide. 
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Figure 2: Image of a goiter, taken from Zimmerman (2) 
  
 
Serum thyroglobulin is a sensitive measurement of both iodine deficiency and 
iodine excess (20).  Zimmerman et al. demonstrated that there is a significant greater 
amount of thyroglobulin present in children with iodine-deficiency (with a UIC of less 
than 100 mcg/L) and in children with iodine excess (with a UIC of greater than 300 
mcg/L) (20).  Therefore, it was shown that over the range of severely deficient to excess 
iodine intake, the thyroglobulin concentrations demonstrate a U-shaped graph. This study 
further concluded that a median thyroglobulin amount of <13 µg/L indicates iodine 
sufficiency in a population.  
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Figure 3: Scatterplot of thyroglobulin concentrations vs. UIC of children age 6-12 
years from 12 countries (20) 
 
 
The estimated iodine requirement by age and population group is presented in Table 2 
below from the U.S. Institute of Medicine (IOM) (16).   
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Table 2. Recommendations for iodine intake (µg /d) by age or population group 
 
Age or 
population 
group 
Institute of 
Medicine’s 
EAR 
Institute of 
Medicine’s 
RDA 
Age or 
population 
group 
World Health 
Organization’s 
RNI 
Infants 0-12 
months 
 110-130 * Children 0-5 
years 
90 
Children 1-8 
years 
65 90 Children 6-12 
years 
120 
Children 9-13 
years 
73 120  
Adults ≥ 14 
years 
95 150 Adults > 12 
years 
150 
Pregnancy 160 220 Pregnancy 250 
Lactation 200 290 Lactation 250 
* AI for infants since an RDA has not been defined for this group 
(Table 2) Recommendations for iodine intake (µg /d) by age and population group. 
From U.S. Institute of Medicine (16); and World Health Organization (8) 
 
The estimated average requirement (EAR) is defined as the daily intake of iodine that 
is sufficient for half of the individuals of a certain age group and is used to assess groups 
and not individuals (16). The recommended dietary allowance (RDA) is the average daily 
intake of iodine that meets the requirement of 97-98% of healthy individuals of a 
particular population group and is used to assess the daily iodine intake of an individual 
(16). The adequate intake (AI) is provided only if there is insufficient data to calculate the 
EAR and is assumed to meet or exceed the concentration of iodine required in all of the 
participants in a certain group, and may be used as an aim for individual intake (16).  
According to World Health Organization (WHO) standards, the recommended nutrient 
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intake (RNI) is the daily dietary intake of iodine that sufficiently meets the needs of 
basically all of the individuals of a group (8). 
There are several methods that can effectively measure the iodine status of a 
population. Since >90% of iodine consumed eventually enters the urine, median spot 
urinary iodine concentrations (UIC) serve as an indicator for recent population dietary 
iodine intake (18).  Urinary median thresholds are used to identify urinary dietary iodine 
sufficiency in populations yet cannot be used to measure the status of individuals due to 
large variation in individuals’ daily iodine intake (19).  Because of this day-to-day 
fluctuation, approximately ten repeat spot urine collections are required in order to 
accurately measure individual iodine intake (23 and 24).  Table 2 is adapted from WHO 
criteria for assessing iodine nutrition in a population based on the median urinary iodine 
values (8).   
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Table 3. Epidemiological criteria from the WHO for assessment of iodine nutrition 
(8)  
Urinary Iodine (µg/liter) Iodine Intake Iodine Status 
School aged children 
<20 Insufficient Severe iodine deficiency 
20-49 Insufficient Moderate iodine 
deficiency 
50-99 Insufficient Mild iodine deficiency  
100-199 Adequate Optimal 
200-199 More than adequate Risk of iodine-induced 
hyperthyroidism  
>300 Excessive Risk of adverse health 
consequences  
Pregnant Women 
<150 Insufficient  
150-249 Adequate  
250-499 More than adequate  
≥500 Excessive  
Lactating women 
<100 Insufficient  
≥100 Adequate  
Children less than 2 years old 
<100 Insufficient  
≥100 Adequate   
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Iodine requirements during pregnancy  
 
Starting in the first trimester, maternal thyroid hormone production increases by 
around 50%.  Early in gestation, both TSH and human chorionic gonadotropin (hCG) 
stimulate the thyroid gland.  hCG is a hormone produced by the syncitioblast of the 
developing embryo during the first trimester and its alpha subunit binds to and stimulates 
the TSH receptor (24).  During pregnancy, this hCG-induced stimulation of the thyroid 
gland is responsible for the rapid increase in thyroxine production near the end of the first 
trimester (25). This, in turn, activates the negative feedback on the pituitary gland and 
decreases TSH concentrations.   
Pregnancy is also associated with an increase in serum thyroxine-binding globulin 
(26). Elevated levels of estrogen during pregnancy cause an increase in the sialylation of 
thyroxine-binding globulin, thereby reducing hepatic clearing of TBG and resulting in an 
increased its concentration in the circulation. Due to the increase in the binding protein, 
the levels of total T3 and T4 increase by 50% during pregnancy.  
Another result of pregnancy is the modification of metabolism of thyroid 
hormone due to elevated deiodination activity within the placenta.  The iodothyronine 
deiodinases expressed in the placenta are type 3 (D3), which converts T4 to rT3, and type 
2 (D2), which generates inactive T2 from T3 (27).  The placental deiodinases, thus, 
deactivates the thyroid hormone, thereby protecting the fetus from excessive hormone 
exposure.  The overall increase in thyroid hormone degradation in the placenta 
contributes to the increased demand of maternal thyroid hormone synthesis. 
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Starting early in gestation, there is a significant increase in urinary iodine loss due 
to the increase in glomerular filtration rate (26).  Since iodine is excreted passively, the 
increased maternal renal glomerular filtration causes a higher renal clearance of ingested 
iodine (28). 
By 10-12 weeks of gestation, the fetal thyroid gains the ability to accumulate 
iodine, yet is unable to organify the iodine (i.e. to produce thyroid hormone) until about 
the 16th-20th week (29).  Prior to this point, maternal thyroid hormone production must be 
adequate in order to meet the fetal metabolic requirements.  Once thyroid function is 
established in the fetus, its iodine turnover is much higher than that of adults (30 & 31). 
As a result of the increase in the production of thyroid hormone, increased urinary 
iodine loss, and fetal iodine requirements, dietary iodine intake must be higher during 
pregnancy than in non-pregnant adults. The World Health Organization recommends an 
intake of 250mcg/day of iodine, in comparison to 150 mcg/day for non-pregnant adults 
(8). 
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Figure 4. TRH-thyrotropin axis during pregnancy, taken from Karaca et al. (32) 
 
 
 
Effects of Iodine Deficiency During Pregnancy  
Thyroid hormone, which is dependent on the consumption of adequate iodine, is 
crucial for fetal neurodevelopment and physical growth during pregnancy (33). Since the 
fetus is unable to synthesize its own thyroid hormone until weeks 16-20 of gestation, in 
early gestation it is entirely dependent on the low concentrations of maternal thyroid 
hormone that cross the placenta. Women with sufficient iodine intake prior and 
throughout pregnancy will have an adequate amount of iodine within the thyroid gland 
and will be able to adapt to the increased demand for thyroid hormone production during 
	  14	  
 
gestation. However, women living in iodine-deficient areas are unable to compensate or 
adapt.  Even minimally low maternal T4 levels during pregnancy may result in higher 
rates of miscarriages, congenital abnormalities, and mental impairment (8, 34, 35, 40, 41). 
Iodine deficiency is the leading cause of preventable mental retardation worldwide, as it 
affects 38% of the global population (36). 
Thyroid hormone affects neuronal migration, myelination of axons, synaptic 
transmission, and plasticity throughout neurodevelopment (37 and 38).  It plays a crucial 
role in the timing of the differentiation of oligodendrocytes and regulates the expression 
of enzymes involved in the formation of lipids and in the expression of proteins found in 
the structure of myelin (38).  The consequences of hypothyroidism and iodine deficiency 
on fetal neuronal development depend upon timing and the severity of the 
hypothyroxinemia. Even mild maternal hypothyroidism during pregnancy may cause 
disrupted neuronal migration in the fetus, resulting in ectopic neurons in different cortical 
layers of the brain (39).  Severe maternal iodine deficiency may result in several negative 
effects on the fetus, including: decreased intelligence, congenital anomalies and 
neurological cretinism (22).  The characteristic features of cretinism are severe mental 
retardation with squint, deaf mutism, and motor spasticity (15).  
The results of mild-to-moderate iodine deficiency during pregnancy are not as 
well characterized as those of severe iodine deficiency.  A study by Bath et al. examined 
the effect of mild iodine deficiency in UK pregnant women and its effect of the cognitive 
development in their children (40).  They measured the UIC of pregnant women in their 
first trimester and then measured the IQ of their children at 8 years old.  It was found that 
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offspring of women with an iodine-to-creatine ratio of less than 150 µg/g were more 
likely to have scores in the lowest quartile for verbal IQ, reading accuracy, and reading 
comprehension than women with ratios of 150 µg/g or more (40). Another recent study 
by Hynes et al. examined mild iodine deficiency in pregnant women and the standardized 
test performance outcomes of their 9-year-old children (41).  It was demonstrated that 
children of women who were mildly iodine deficient in pregnancy (UIC < 150 µg/L) had 
score reductions of 10% in spelling, 7.6% in grammar, and 5.7% in English literature 
performance in comparison to children of mothers with normal iodine levels (41).  Both 
studies, therefore, provide evidence that even mild iodine deficiency during pregnancy 
may result in long-term adverse neurocognitive effects on the child. 
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Table 4. Effects of inadequate maternal iodine status on cognitive outcomes in their 
children, results taken from Bath et al. on the (40) 
 
 
Potential Effects of Thiocyanate Exposure 
 Thiocyanate acts as a competitive inhibitor of the sodium/iodine symporter (NIS), 
and therefore decreases thyroidal iodine uptake.  Environmental exposure, therefore, may 
disrupt thyroid function (42).  Thiocyanate is derived mainly from certain foods and from 
cigarette smoke.  Thiocyanate is metabolized both from cigarette smoke within the body, 
and is also a metabolite of cyanogenic glucosides which are found in certain plant foods, 
like cabbage, broccoli, cassava and rapeseed oil (43).  Exposure to thiocyanate has been 
shown to increase the risk of the development of goiter in populations with moderate-to-
severe iodine deficiency (44). Studies have shown that maternal smoking throughout 
pregnancy is associated with changes in fetal and maternal thyroid function; including: 
lower T4 levels, increased serum TSH levels, and thyroid enlargement (45 & 46). FT4 
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levels were lower in smokers during the first trimester of pregnancy than in nonsmokers, 
which may potentially be linked to thiocyanate exposure (47).  Vanderver et al. reported 
that smoking in women in childbearing years is correlated with a higher rate of 
hypothyroxinemia, yet this is only present in women with the highest urinary iodine 
concentrations (48). Chanoine et al. reported that in regions of borderline low iodine 
intake, smoking throughout pregnancy was significantly correlated with the presence of 
goiters and elevated amounts of serum thyroglobulin in infants (49). It has also been 
shown that the thiocyanate found in cigarette smoke competitively inhibits the NIS 
responsible for the transport of iodide in the lactating mammary gland. Lauberg et al. 
demonstrated that smoking while breastfeeding reduced the amount of iodine transferred 
through breast milk, thereby potentially increasing the risk of impaired 
neurodevelopment of the infant (49).  
 
Iodine Status in the US  
 Since the 1940s, dietary iodine in the United States has been adequate overall, 
even though the adult median urinary concentration dropped from 320 mcg/L when the 
first National Health and Nutrition Examination Survey (NHANES I) was done in the 
1970s to 145 mcg/L at the time of NHANES III in the early 1990s (50). What is 
particularly alarming is the fact that the prevalence of urinary iodine concentration values 
of <50 mcg/L among women of childbearing age almost quadrupled from 4% to 15% 
over these 20 years. The most recent examination of the iodine status of the United States, 
from NHANES 2009-2010, demonstrated that the population median UIC was 144 µg /L, 
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which is significantly lower than the median value of 164 µg /L from NHANES 2007-
2008 (51).  The median UIC for all women was 134 µg /L, and the UI for women of 
childbearing years, ages 15-44 years, was 124 µg /L.  The UI concentration for women of 
childbearing years has been consistently lower than the general population since 2001 
(51) (Figure 5).  The median UI for pregnant women recorded in NHANES 2009-2010 
was 135 µg /L, suggesting mild iodine deficiency.  NHANES data from 2007-2010 
indicated that 37.3% of nonpregnant women of childbearing years have median UI 
concentrations less than 100 µg /L, while 55.8% of pregnant women have UI 
concentrations less than 150 ug/L. 
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Figure 5: Median urinary iodine concentration for participants older than 6 years 
old and women of childbearing age based on NHANES 2001-2010, from Caldwell et 
al. (52)   
 
 
 
Due to the concern about mild iodine deficiency in pregnant women in the US, 
there have been public health recommendations for iodine supplementation, for women 
planning a pregnancy, during pregnancy, and during lactation. The American Thyroid 
Association, Endocrine Society, and Teratology Society have recommended that all 
pregnant women and women planning a pregnancy should receive dietary 
supplementation containing 150 µg /day of iodine and that all US prenatal vitamins 
should contain 150 µg of iodine daily (53, 54, 55). However, iodine content of prenatal 
vitamins is not mandated in the US.  Only 51% of the types of prenatal vitamins available 
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in the United States contain iodine and only 20% of US pregnant women surveyed from 
2001-2006 reported routinely taking iodine-containing supplements (56 & 57).  
 
Iodine Deficiency in Haiti  
 Located only 500 miles from Florida, Haiti has a population of 8 million people, 
including 1 million newborns annually who are potentially at risk for iodine-deficiency 
(58).  There are currently 29,000 Haitian children each year born each year with cretinism 
and mental impairment as a result of iodine deficiency (59).  Despite decades of 
international public health efforts, the household consumption of iodized salt has 
decreased from 11% in 2000 to 3% in 2005, making it the lowest in the Western 
Hemisphere (60).  UNICEF Haiti has attempted to supply the equipment for salt 
iodization, yet their efforts could not be completed due to social and political barriers.  
We postulate that Haitian immigrant women living in the US may have unique dietary 
patterns and also may frequently travel back and forth to Haiti and therefore may be 
particularly at risk for iodine deficiency during pregnancy.   
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Figure 6: Iodine nutrition based on the median urinary iodine concentration, by 
country; taken from Zimmermann et al. (60) 
 
 
The purpose of this study is to determine the iodine status of a cohort of pregnant 
Haitian-American women living the Boston-area. This is the first study to specifically 
examine the relationships among iodine and cigarette smoking on urinary iodine levels 
during pregnancy in this population.  
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METHODS 
Subjects 
 The study population included pregnant Haitian women seeking prenatal care at 
the Boston Medical Center (BMC) Antenatal clinic. About 2,600 women per year deliver 
at BMC, of whom 40% receive their prenatal care there and the rest at affiliated 
community health clinics.  Approximately 14% of the patients who routinely attend the 
BMC Obstetrics clinic are of Haitian ethnicity. Haitian women receiving prenatal care at 
the Antenatal clinic at BMC were eligible to participate.  
Inclusion criteria included fluency in either English or Haitian Creole. Women 
carrying two or more fetuses were excluded from the study.  Women with a history of 
thyroid disease or those taking thyroid hormone or anti-thyroid medications were 
excluded.  Women who had undergone any radiologic studies with iodinated intravenous 
contrast agents within six months were also excluded.  Written informed consent was 
obtained from all participants.  The BUMC IRB approved the study. 
 
Study Measures: 
Participants completed a questionnaire regarding their age, ethnicity, smoking 
behavior (do they smoke or live with people that smoke), whether or not they take 
prenatal vitamins, if they drink milk each day (and if so, how many glasses), and when 
was their last visit to Haiti that exceeded 6 months.  In order to determine if the women 
were taking iodine-containing prenatal supplements, they were asked to describe the 
brand, type (prescription vs. nonprescription) and the frequency of use.  Spot urine 
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specimens were obtained from all women in order to measure the concentrations of 
iodine. 
 
Sample Size 
 We relied on the model determined by Andersen et al. which calculated that spot 
urine samples from 125 individuals are required in order to estimate the iodine level of a 
population with 95% confidence within a precision range of ±10% (18).  Study results 
thus far are only preliminary, and more participants need to be enrolled in order to reach 
the target sample size. 
  
Laboratory Measures: 
 All of the laboratory measurements on the urine specimens were performed at the 
Boston University Iodine, Perchlorate and Thyroid Function Test Research Laboratory.  
Prior to the iodine analysis, all urine samples were stored at -80º C.  The total urinary 
iodine content was measured spectrophotometrically by a modification of the method of 
Benotti et al. (61).  This procedure required a minimum number of reagents, and 
therefore reduces the chance of reagent contamination.  The cost of this method is lower 
than other methods for iodine determination and recovers the iodine accurately and well 
(61).  The assay required the addition of 0.5 ml of chloric acid to 0.1 ml of urine.  After 
the sample was digested for 20 minutes, 2.1 ml of arsenious acid was added and then put 
through automated analysis.  Since only 0.1 ml of urine is used for the screening, it is 
possible to accurately measure the content of the iodine in it (61).  
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Figure 7: Average recovery of iodine from biological matter, taken from Benotti et 
al. (61). 
 
 
Statistical Analysis 
 Descriptive statistics were provided for each outcome measure.  The statistics for 
continuous variables included mean, standard deviation, median and range. Categorical 
variables were described by frequency. Median urinary iodine values were compared to 
the threshold values provided by the World Health Organization in order to determine 
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whether the population was iodine-sufficient.  According to WHO guidelines, median 
urinary iodine concentrations of 150-249 mcg/L in pregnant women were considered 
iodine-sufficient.  
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RESULTS 
 
 
Population: 
 The majority of the sample population, which consisted of 21 women, was born in 
Haiti and had returned to Haiti for at least 6 months within the last 5 years.  The age of 
participants ranged from 21 to 36 years old, with an average age of 31.6 ± 4.5.  None of 
the women reported smoking, nor were they living with someone that smoked.  Eighty-
six percent of the women were taking prenatal vitamins, of which most were prescribed 
by the physician and obtained at the pharmacy in the Boston Medical Center, which 
stocks only one brand supplemented with 150 µg of iodine out of 6 brands. The majority 
of the women (around 90%) reported drinking milk daily throughout their pregnancy, 
with an average of 1.3 glasses per day ± 0.89.  Ninety percent of the women reported that 
they were born in Haiti, while the other 10% are second-generation Haitian Americans 
living in the Boston area.  All of the women have reported having spent at least 6 months 
in Haiti, with 38% of them having travelled there within the last 2 years.   
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Table 5. Study Population  
 
Age  
(Mean ± SD) 
31.6 ± 4.5 
Born in Haiti #  
(%) 
19 (90%) 
Spent 6 months or more in Haiti within 
the last 2 years # 
(%) 
8 (38%) 
Reported “Yes” to smoking #  
(%) 
0 (0%) 
Glasses of milk/day  
Mean ± SD 
 
1.3 ± 0.89 
Reported “Yes” to taking prenatal 
vitamins #  
(%) 
18 (86%) 
Urinary iodine concentration (mcg/L) 
Median (range) 
162.7 (52.7-471.1) 
 
Urinary Iodine Concentrations 
 The median urinary iodine level was 162.7 mcg/L, and iodine concentrations 
ranged from 52.7 to 471.1. The lower 95% confidence interval was 124.4 mcg/L and the 
upper 95% confidence interval was 237.9 mcg/L. According to WHO standards for 
iodine status during pregnancy, the median value of 162.7 mcg/L is considered to be 
iodine sufficient.  Given that none of the women enrolled thus far reported cigarette 
smoke exposure, we are unable to determine whether UIC differed in women who 
smoked or had secondhand smoke exposure. 
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DISCUSSION 
 Because iodine is critically important for adequate thyroid hormone production 
and normal neurodevelopment of the fetus, pregnant women are the most vulnerable 
population to iodine deficiency.  In our Boston-area sample of pregnant Haitian 
American, we found a median urinary iodine value of 162.7 mcg/L. These data, although 
preliminary, suggest that the dietary intake of iodine in this group is sufficient according 
to WHO standards, since the median exceeds 150 mcg/L. This is the first study of its kind 
to look at the iodine status of this population.  Additional analyses are needed in order to 
look at predictors of iodine status and thyroid function in pregnancy in this subgroup of 
women. 
 
Comparison of Results to Previous Studies  
 A study performed in 2004 examined the urinary iodine concentrations of 100 
Boston-area pregnant women at BMC and found a marginal median urinary iodine level 
of 149 mcg/L (62).  The median urinary iodine value found in our study is slightly higher 
than the 2004 study.  
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Figure 8: Urinary iodine concentrations in 100 Boston area pregnant women (62) 
 
  
 
Another recent study in Toronto, Canada evaluated the iodine status of pregnant 
women who presented for routine antenatal care (63).  One hundred forty-two women 
were recruited at the clinics in Toronto where they completed a questionnaire and 
provided spot urine specimens to measure urinary iodine concentration (UIC).  The mean 
maternal age was 33.8 ± 4.3 years and the median UIC was 221µg/L. Six women (4.2 %) 
had iodine levels that were less than 50 µg/L, and 36 women (25.4%) had levels between 
50 and 150 µg/L.  This study included mainly Caucasian, well-educated and affluent 
Canadian women.  Dietary and lifestyle factors were likely quite different from the 
Haitian American women in the present study.  
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  In the NHANES study of 2009-2010, it was found that the median urinary iodine 
concentration for pregnant U.S. women was 135 µg/L (52).  Among these women, 
approximately 55.8% had a urinary iodine concentration of less than 150 mcg, suggesting 
inadequate iodine (52).  When comparing this data to the data found in our study, it was 
shown that only 38% of the pregnant population at the BMC Antenatal Clinic had a 
median urinary iodine concentration of less than 150 mcg.  Pregnant women in the third 
trimester participating in the National Children’s Study (NCS) had a median urinary 
iodine concentration of 167 µg/L, while the median UIC for women in their third 
trimester in NHANES 2005-2010 was 172 µg/L (52).  Of the women that participated in 
the NCS study, 45.3% had median urinary iodine concentrations of less than 150 µg/L 
(52).   
 
Strengths and Limitations  
 This study was novel because we were able to examine a population that has 
never previously been studied. We were able to gather information about potential 
predictors of iodine deficiency in the Haitian American pregnant population living in 
Boston.  These predictors will be used in multivariable statistical models when the full 
study sample has been enrolled.  Another strength was that the questionnaire was in 
Haitian Creole and we were able to communicate with the women in their own language. 
Urinary iodine concentrations are a reliable biomarker for iodine status.  
 The main weakness of this study was that the data are preliminary and numbers 
are small, so we therefore need to await completion of the study in order to reach a more 
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definitive conclusion about the iodine status of this population.  We relied on self-report 
when the patients answered the questionnaires, which may have resulted in some 
misclassification. We didn’t measure thyroid function. We did not assess exposure to 
perchlorate, thiocyanate and other potential environmental thyroid disruptors. Since we 
only gathered urine at one time point during pregnancy, we were unable to assess 
possible variations in iodine concentrations throughout pregnancy.  Lastly, the targeted 
population was slightly heterogeneous since some individuals were born in Haiti and 
others grew up in US. 
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CONCLUSION 
In conclusion, the preliminary data from this study are reassuring, suggesting that 
this Haitian American pregnant population in the Boston area is likely iodine sufficient. 
Further studies could include an examination of the iodine status of pregnant women 
living in Haiti, a comparison of thyroid function in Haitian women living in the US 
versus those living in Haiti, and could explore environmental goitrogens and their effect 
on thyroid function in both groups.  
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